Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis

Clinical trial NCT00497952 · WITHDRAWN

Trial details

NCT number: NCT00497952
Sponsor: Talaris Therapeutics Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2007-07-01
Primary completion: 2024-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.